The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119
The Concept of a Blood-Brain Barrier
(1980) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(80)90073-7 · Cited by 790
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Self-citationShepro, D., & Morel, N. M. L. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370472 · Cited by 635
Physiology of the CSF and Blood-Brain Barriers
Davson, H., & Segal, M. B. (1996) · Medical Entomology and Zoology · Cited by 582
Tight Junctions of the Blood–Brain Barrier
Kniesel, U., & Wolburg, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006995910836 · Cited by 519
Electrical resistance of brain microvascular endothelium
Crone, C., & Olesen, S. P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91227-6 · Cited by 491
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Self-citationThe Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Is the histaminergic neuron system a regulatory center for whole-brain activity?
Wada, H., Inagaki, N., Yamatodani, A., & Watanabe, T. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90034-r · Cited by 380
Research works printed but not linked: 27
- Abbott, N. J., Roux, F., Couraud, P.-O., and Begley, D. J. (1995). Studies on an immortalized brain endothelial cell line: Differentiation, permeability and transport. In Greenwood, J., Begley, D. J., and Segal, M. B. (eds.), New Concepts of a Blood-Brain Barrier, Plenum Press, New York, pp. 239-249. · doi:10.1007/978-1-4899-1054-7_24
- Boarder, M. R., and Hourani, S. M. O. (1998) The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors. Trends Pharmacol. Sci. 19:99-107. · doi:10.1016/s0165-6147(98)01170-5
- Curry, F. E. (1992). Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB J. 6:2456-2466. · doi:10.1096/fasebj.6.7.1563597
- Easton, A. S., and Abbott, N. J. (1997). The effects of bradykinin on a cell culture model of the blood-brain barrier. J. Physiol. 505:49-50P.
- Easton, A. S., and Fraser, P. A. (1994). Variable restriction of albumin diffusion across inflamed cerebral microvessels. J. Physiol. 475:147-157. · DOI
- Feolde, E., Vigne, P., Breittmayer, J. P., and Frelin, C. (1995). ATP, a partial agonist of atypical P2Y purinoceptors in rat brain microvascular endothelial cells. Br. J. Pharmacol. 115:1199-1203. · DOI
- Frelin, C., Breittmayer, J. P., and Vigne, P. (1993). ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells. J. Biol. Chem. 268:8787-8792. · doi:10.1016/s0021-9258(18)52943-4
- Hardebo, J. E., Owman, Ch., and Wiklund, L. (1981). Influence of neurotransmitter monoamines and neurotoxic analogues on morphological blood-brain barrier function. In Cervos-Navarro, J., and Fristschka, E. (eds.), Cerebral Microcirculation and Metabolism, Raven Press, New York, pp. 177-180.
- He, P., and Curry, F. E. (1993). Differential actions of cAMP on endothelial [Ca2+]i and permeability in microvessels exposed to ATP. Am. J. Physiol. 265:H1019-1023.
- He, P., and Curry, F. E. (1994). Endothelial hyperpolarization increases [Ca2+]i and venular microvessel permeability. J. Appl. Physiol. 76:2288-2297. · doi:10.1152/jappl.1994.76.6.2288
- Kurokawa, T., and Fraser, P. A. (1995). A bradykinin antagonist prevents cerebral microvascular permeability increase following reperfusion in rats. Physiol. 483:140P.
- Maier-Hauff, K., Baethmann, A. J., Lange, M., Schurer, L., and Unterberg, A. (1984). The kallikreinkinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue. J. Neurosurg. 61:97-106. · doi:10.3171/jns.1984.61.1.0097
- Neal, C. R., and Michel, C. C. (1992). Transcellular openings through microvascular walls in acutely inflammed frog mesentery. Exp. Physiol. 77:917-920. · doi:10.1113/expphysiol.1992.sp003659
- Nobles, M., and Abbott, N. J. (1996). Effects of cyclic nucleotides on the increase in [Ca2+]i caused by external ATP in the brain endothelial cell line, RBE4. J. Physiol. 491:38P.
- Ohnishi, T., Posner, J., and Shapiro, W. R. (1992). Vasogenic brain edema induced by arachidonic acid: Role of extracellular arachidonic acid in blood-brain barrier dysfunction. Neurosurgery 30:545-551.
- Sardesai, V. M. (1992). Biochemical and nutritional aspects of lipoproteins and leukotriene biosynthesis as potential therapeutic targets. Progr. Drug Res. 37:9-90.
- Sarker, M. H., and Fraser, P. A. (1994). Evidence that bradykinin increases permeability of single cerebral microvessels via free-radicals in the rat. J. Physiol. 479:36P.
- Sarker, M. H., and Fraser, P. A. (1996). Effect of 5-HT in the regulation of cerebral microvascular permeability in the anaesthetized rat. J. Physiol. 491:29-30P.
- Sarker, M. H., and Fraser, P. A. (1998). Evidence that bradykinin increases cerebral microvascular permeability via cGMP generated independently from soluble guanylate cyclase in the anaesthetized rat. J. Physiol. 506:22P.
- Schulze, C., and Firth, J. A. (1993). Junctions between pericytes and the endothelium in rat myocardial capillaries: A morphometric and immunogold study. Cell Tissue Res. 271:145-154. · doi:10.1007/bf00297552
- Sharma, H. S., and Dey, P. K. (1986a). Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology 25:161-167. · doi:10.1016/0028-3908(86)90037-7
- Sharma, H. S., Olsson, Y., and Westman, J. (1995) A serotonin inhibitor, p-chlorophenylalanine reduces the heat-shock protein response following trauma to the spinal cord–An immunohistochemical and ultrastructural study in the rat. Neurosci. Res. 21:241-249. · DOI
- Vigne, P., Lund, L., and Frelin, C. (1994). Cross talk among cyclic AMP, cyclic GMP, and Ca2+-dependent intracellular signalling mechanisms in brain capillary endothelial cells.J. Neurochem. 62:2269-2274. · doi:10.1046/j.1471-4159.1994.62062269.x
- Vigne, P., Feolde, E., Breittmayer J. P., and Frelin, C. (1994). Characterization of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells: similarities to ADP and differences from ATP. Br. J. Pharmacol. 112:775-780. · doi:10.1111/j.1476-5381.1994.tb13146.x
- Webb, T. E., Feolde, E., Vigne, P., Neary, J. T., Runberg, A., Frelin, C., and Barnard, E. A. (1996) The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br. J. Pharmacol. 119:1385-1392. · DOI
- Winkler, T., Sharma, H. S., Stalberg, E., Olsson, Y., and Dey, P. K. (1995). Impairment of bloodbrain barrier function by serotonin induces desynchronization of spontaneous cerebral cortical activity-Experimental observations in the anesthetized rat. Neuroscience 68:1097-1104. · doi:10.1016/0306-4522(95)00194-n
- Wolburg H., and Risau, W. (1995). Formation of the blood-brain barrier. In Kettenmann, H., and Ransom, B. R. (eds.), Neuroglia, Oxford University Press, Oxford, pp. 763-776.
Cited by
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Self-citationThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172
“…tight junction expression during peripheral inflammatory pain (Huber et al., 2002) Inflammatory mediators Effect demonstrated with (reviewed in Abbott, 2000): Bradykinin Serotonin Histamine Arachidonic acid Nitric oxide Cytokines Effect demonstrated with: TNF-a (Tsao et al., 2001) IL-1b (de…”
Astrocyte-endothelial Interactions and Blood-Brain Barrier Permeability*
Abbott, N. J. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00064.x · Cited by 1,168
Self-citationModern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
“Intracellular Ca2+ is also central to the regulation of TJ integrity (Abbott 2000).”
BackgroundChen, Y., & Swanson, R. A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200302000-00001 · Cited by 912
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 893
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882
Patton, N., Aslam, T., MacGillivray, T., Pattie, A., Deary, I. J., & Dhillon, B. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00395.x · Cited by 807
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
Abbott, N. J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.006 · Cited by 786
Self-citationMolecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Booth, R., & Kim, H. (2012) · Lab on a Chip · doi:10.1039/c2lc40094d · Cited by 739
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643
Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569
Neurological consequences of obesity
O'Brien, P. D., Hinder, L. M., Callaghan, B. C., & Feldman, E. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30084-4 · Cited by 533
Kang, L., Yu, H., Yang, X., Zhu, Y., Bai, X., Wang, R., Cao, Y., Xu, H., Luo, H., Lu, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16191-y · Cited by 531
Guillemin, G. J., & Brew, B. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303114 · Cited by 525
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S., Keep, R., & Andjelkovic, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 513
WANG, D., & BORDEY, A. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.015 · Cited by 502
Basic principles of immunological surveillance of the normal central nervous system
Hickey, W. F. (2001) · Glia · doi:10.1002/glia.1101 · Cited by 476
Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation
Abbott, N. J. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1374-y · Cited by 469
Self-citationPro‐regenerative properties of cytokine‐activated astrocytes
Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W., & Levison, S. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02420.x · Cited by 464
Muneer, P. M. A., Chandra, N., & Haorah, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8752-3 · Cited by 459
Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology
SU, C.-Y., MING, Q.-L., RAHMAN, K., HAN, T., & QIN, L.-P. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)30002-9 · Cited by 412
The effects of hypertension on the cerebral circulation
Pires, P. W., Dams Ramos, C. M., Matin, N., & Dorrance, A. M. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00490.2012 · Cited by 408
Stamatovic, S. M., Keep, R. F., Kunkel, S. L., & Andjelkovic, A. V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00755 · Cited by 381
Perets, N., Betzer, O., Shapira, R., Brenstein, S., Angel, A., Sadan, T., Ashery, U., Popovtzer, R., & Offen, D. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04148 · Cited by 382
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
Kempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P. A., Iyer, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00216 · Cited by 365
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
“A leaky barrier increases the brain’s susceptibility to toxins and pathogens and homeostasis disruption, and ultimately, neuronal dysfunction (Abbott, 2000; Hutchinson, 2010; Ikeshima-Kataoka and Yasui, 2016; Block, 2019).”
Backgroundde Boer, A. G., & Gaillard, P. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 348
Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments
Donkin, J. J., & Vink, R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328337f451 · Cited by 347
Understanding the role of the perivascular space in cerebral small vessel disease
Brown, R., Benveniste, H., Black, S. E., Charpak, S., Dichgans, M., Joutel, A., Nedergaard, M., Smith, K. J., Zlokovic, B. V., & Wardlaw, J. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy113 · Cited by 336
Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier
Nyberg, S., Abbott, N. J., Shi, X., Steyger, P. S., & Dabdoub, A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0935 · Cited by 336
Self-citationRezaie, P., & Dean, A. (2002) · Neuropathology · doi:10.1046/j.1440-1789.2002.00438.x · Cited by 332
Type I glutaric aciduria, part 1: Natural history of 77 patients
Strauss, K. A., Puffenberger, E. G., Robinson, D. L., & Morton, D. H. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.20007 · Cited by 325
ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents
Dunger, D. B. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.044875 · Cited by 321
Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation
Denes, A., Thornton, P., Rothwell, N. J., & Allan, S. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.010 · Cited by 309
Blood–brain barrier breakdown in septic encephalopathy and brain tumours*
Davies, D. C. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00065.x · Cited by 309
Factors controlling permeability of the blood–brain barrier
Almutairi, M. M. A., Gong, C., Xu, Y. G., Chang, Y., & Shi, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 306
Dunger, D. B., Sperling, M. A., Acerini, C. L., Bohn, D. J., Daneman, D., Danne, T. P. A., Glaser, N. S., Hanas, R., Hintz, R. L., Levitsky, L. L., et al. (2004) · Pediatrics · doi:10.1542/peds.113.2.e133 · Cited by 296
Factors influencing the blood-brain barrier permeability
Zhao, Y., Gan, L., Ren, L., Lin, Y., Ma, C., & Lin, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147937 · Cited by 291
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
The spleen contributes to stroke‐induced neurodegeneration
Ajmo, C. T., Vernon, D. O. L., Collier, L., Hall, A. A., Garbuzova‐Davis, S., Willing, A., & Pennypacker, K. R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21661 · Cited by 272
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
Kanner, A. A., Marchi, N., Fazio, V., Mayberg, M. R., Koltz, M. T., Siomin, V., Stevens, G. H. J., Masaryk, T., Ayumar, B., Vogelbaum, M. A., et al. (2003) · Cancer · doi:10.1002/cncr.11409 · Cited by 269
Strbian, D., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., Abo-Ramadan, U., & Tatlisumak, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.012 · Cited by 265
Di Marco, L. Y., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 262
Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials
Tsou, Y., Zhang, X., Zhu, H., Syed, S., & Xu, X. (2017) · Small · doi:10.1002/smll.201701921 · Cited by 258
Blood-brain barrier transport machineries and targeted therapy of brain diseases
Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · BioImpacts · doi:10.15171/bi.2016.30 · Cited by 257
Effects of high-fat diet exposure on learning & memory
Cordner, Z. A., & Tamashiro, K. L. K. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.008 · Cited by 257
Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion Injury
Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600229 · Cited by 252
“In contrast, in the later phase (24 to 48 h), ‘opening’ is associated with the production of proinflammatory cytokines (interleukin (IL)-1b and tumor necrosis factor (TNF)-a) and regulators of leukocyte trafficking (such as intercellular adhesion molecule-1 (ICAM-1) and IL-8), as well as leukocyte migration (Abbott, 2…”
BackgroundHorie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., Shamloo, M., Hamilton, S. A., Jiang, K., Huhn, S., et al. (2011) · Stem Cells · doi:10.1002/stem.584 · Cited by 240
The function of gut microbiota in immune-related neurological disorders: a review
Sittipo, P., Choi, J., Lee, S., & Lee, Y. K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02510-1 · Cited by 221
Pearson-Leary, J., Zhao, C., Bittinger, K., Eacret, D., Luz, S., Vigderman, A. S., Dayanim, G., & Bhatnagar, S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0380-x · Cited by 206
Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189
Blood-brain barrier function in intracerebral hemorrhage
Keep, R. F., Xiang, J., Ennis, S. R., Andjelkovic, A., Hua, Y., Xi, G., & Hoff, J. T. (2009) · Acta Neurochirurgica Supplementum · doi:10.1007/978-3-211-09469-3_15 · Cited by 185
TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183
The blood-nerve barrier: structure and functional significance
Weerasuriya, A., & Mizisin, A. P. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-938-3_6 · Cited by 164
Evidence of angiogenic vessels in Alzheimer’s disease
Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M., & Hendey, B. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0226-9 · Cited by 153
Kaneko, N., Kudo, K., Mabuchi, T., Takemoto, K., Fujimaki, K., Wati, H., Iguchi, H., Tezuka, H., & Kanba, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301137 · Cited by 152
“IL-1b protein expression is rapidly induced within a few hours after brain injury, and acts to amplify the inflammatory process, implying that IL-1b in the CNS may trigger sequential neuropathological processes (Abbott, 2000; Huber et al, 2001; Rothwell, 1999; Turrin et al, 2001), causing depressive symptoms.”
InfluentialKim, S. Y., Buckwalter, M., Soreq, H., Vezzani, A., & Kaufer, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03701.x · Cited by 145
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., & Nakayama, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6503 · Cited by 143
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122254 · Cited by 121
Age-associated changes in the blood-brain barrier: comparative studies in human and mouse.
Goodall, E. F., Wang, C., Simpson, J. E., Baker, D. J., Drew, D. R., Heath, P. R., Saffrey, M. J., Romero, I. A., & Wharton, S. B. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12408 · Cited by 120
Cell types of origin of the cell-free transcriptome
Vorperian, S. K., Moufarrej, M. N., Tabula Sapiens Consortium, Overall Project Direction and Coordination, Jones, R. C., Karkanias, J., Krasnow, M., Pisco, A. O., Quake, S. R., Salzman, J., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01188-9 · Cited by 116
Role of blood–brain barrier in temporal lobe epilepsy and pharmacoresistance
van Vliet, E. A., Aronica, E., & Gorter, J. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.030 · Cited by 100
Differential receptor-mediated drug targeting to the diseased brain
Rip, J., Schenk, G., & de Boer, A. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902806383 · Cited by 98
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease
Cuevas, E., Burks, S., Raymick, J., Robinson, B., Gómez-Crisóstomo, N. P., Escudero-Lourdes, C., Lopez, A. G. G., Chigurupati, S., Hanig, J., Ferguson, S. A., et al. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1859729 · Cited by 57
Role of pattern recognition receptors of the neurovascular unit in inflamm-aging
Wilhelm, I., Nyúl-Tóth, Á., Kozma, M., Farkas, A. E., & Krizbai, I. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00106.2017 · Cited by 56
Brown, R. C., Wu, L., Hicks, K., & O'neil, R. G. (2008) · Microcirculation · doi:10.1080/10739680701762656 · Cited by 56
Zhu, C.-L., Xie, J., Liu, Q., Wang, Y., Li, H.-R., Yu, C.-M., Li, P., Deng, X.-M., Bian, J.-J., & Wang, J.-F. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79913 · Cited by 42
Krisanova, N., Kasatkina, L., Sivko, R., Borysov, A., Nazarova, A., Slenzka, K., & Borisova, T. (2013) · Astrobiology · doi:10.1089/ast.2012.0950 · Cited by 33
“It has been clearly demonstrated that exposure to LD as well as to nano-and microsized particles causes inflammation (Oberdo¨rster et al., 1994; Chatterjee et al., 2010; Bourdon et al., 2012), which is known to alter blood-brain barrier permeability (Abbott, 2000).”
Sáez de Asteasu, M. L., Cuevas-Lara, C., García-Hermoso, A., Ramírez-Vélez, R., Martínez-Velilla, N., Zambom-Ferraresi, F., Cadore, E. L., & Izquierdo, M. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220103 · Cited by 28
Association of hospitalization, critical illness, and infection with brain structure in older adults
Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Mosley, T. H., Alonso, A., Kucharska‐Newton, A., & Brown, C. H. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15470 · Cited by 20
Atherton, E., Brown, S., Papiez, E., Restrepo, M. I., & Borton, D. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-01616-5 · Cited by 10
Metadata
- Authors
- Abbott, N. J.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2000-04
- Volume
- 20
- Issue
- 2
- Pages
- 131-147
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W1560983797
- Cited by
- 803
- References
- 62
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.